Heart failure and hypertrophic cardiomyopathy

I9_HEARTFAIL_AND_HYPERTCARDIOM

No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector
diagram bullet

Check conditions

I9_HYPERTROCARDMYOP

839

diagram downward connector

Filter registries None

0

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

0

diagram downward connector

Check minimum number of events None

0

diagram downward connector
diagram bullet diagram downward connector

Include endpoints

337

diagram downward connector
I9_HEARTFAIL_AND_HYPERTCARDIOM

Extra metadata

First used in FinnGen datafreeze DF5

Summary Statistics

Key figures

All Female Male
Number of individuals 326 115 211
Unadjusted prevalence (%) 0.11 0.07 0.16
Mean age at first event (years) 59.63 60.55 59.12

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: I9_HEARTFAIL_AND_HYPERTCARDIOM – Heart failure and hypertrophic cardiomyopathy
GWS hits: 4

Survival analyses between endpoints

Plot

before Heart failure and hypertrophic cardiomyopathy
after Heart failure and hypertrophic cardiomyopathy

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Heart failure and hypertrophic cardiomyopathy